MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

Nature Medicine

Volumn 15, Issue 1, 2009, Pages 59-67

  Stein, Ulrike ^a,b   Walther, Wolfgang ^a,b   Arlt, Franziska ^a,b   Schwabe, Holger ^b   Smith, Janice ^a   Fichtner, Iduna ^a   Birchmeier, Walter ^a   Schlag, Peter M ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b Section of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1; ONCOPROTEIN; PROLINE; PROTEIN SH3; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOMA; CELLS, CULTURED; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HEPATOCYTE GROWTH FACTOR; MICE; MICE, NUDE; MICE, SCID; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 58149352266     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1889     Document Type: Article

References (50)

1. Christofori, G. New signals from the invasive front. Nature 441, 444-450 (2006).
2. Stein, U. & Schlag, P.M. Clinical, biological and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res. 176, 61-80 (2007).
3. Beahrs, O.H. Staging of cancer of the colon and rectum. Cancer 70, 1393-1396 (1992).
4. Duffy, M.J. et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer 43, 1348-1360 (2007).
5. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
6. Bernards, R. & Weinberg, R.A. A progression puzzle. Nature 418, 823 (2002).
7. Vogelstein, B. & Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (2004).
8. Takayama, T., Miyanishi, K., Hayashi, T., Sato, Y. & Niitsu, Y. Colorectal cancer: genetics of development and metastasis. J. Gastroenterol. 41, 185-192 (2006).
9. Cardoso, J., Boer, J., Morreau, H. & Fodde, R. Expression and genomic profiling of colorectal cancer. Biochim. Biophys. Acta 1775, 103-137 (2007).
10. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 (2003).
11. Mazzone, M. & Comoglio, P.M. The Met pathway: master switch and drug target in cancer progression. FASEB J. 20, 1611-1621 (2006).
12. Sattler, M. & Salgia, R. c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr. Oncol. Rep. 9, 102-108 (2007).
13. Bottaro, D.P. et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804 (1991).
14. Chmielowiec, J. et al. C-Met is essential for wound healing in the skin. J. Cell Biol. 177, 151-162 (2007).
15. Birchmeier, W. et al. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found. Symp. 212, 230-240 (1997).
16. Boccaccio, C. & Comoglio, P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer 6, 637-645 (2006).
17. Di Renzo, M.F. et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1, 147-154 (1995).
18. Fujita, S. & Sugano, K. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. Jpn. J. Clin. Oncol. 27, 378-383 (1997).
19. Fazekas, K., Csuka, O., Koves, I., Raso, E. & Timar, J. Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis. Clin. Exp. Metastasis 18, 639-649 (2000).
20. Takeuchi, H. et al. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin. Cancer Res. 9, 1480-1488 (2003).
21. Kammula, U.S. et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett. 248, 219-228 (2007).
22. Liang, P. & Pardee, A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971 (1992).
23. Ota, T. et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. 36, 40-45 (2004).
24. Dunlevy, J.R., Berryhill, B.L., Vergnes, J.P., SundarRaj, N. & Hassell, J.R. Cloning, chromosomal localization, and characterization of cDNA from a novel gene, SH3BP4, expressed by human corneal fibroblasts. Genomics 62, 519-524 (1999).
25. Miller, R.G. Jr. Survival analysis. Ch.6 (Wiley-Interscience, New York, 1998).
26. Leibovitz, A. et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36, 4562-4569 (1976).
27. Weidner, K.M., Sachs, M. & Birchmeier, W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell Biol. 121, 145-154 (1993).
28. Stoker, M. & Perryman, M. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77, 209-223 (1985).
29. Becker, M. et al. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br. J. Cancer 87, 1328-1335 (2002).
30. Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science 300, 445-452 (2003).
31. Li, S.S. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem. J. 390, 641-653 (2005).
32. Östman, A., Hellberg, C. & Bohmer, F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6, 307-320 (2006).
33. Liu, Y. The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215, 159-169 (1998).
34. Liang, H. et al. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. Int. J. Oncol. 24, 1057-1067 (2004).
35. Boon, E.M., van der Neut, R., van de Wetering, M., Clevers, H. & Pals, S.T. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res. 62, 5126-5128 (2002).
36. Rasola, A. et al. A positive feedback loop between hepatocyte growth factor receptor and β-catenin sustains colorectal cancer cell invasive growth. Oncogene 26, 1078-1087 (2007).
37. Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361 (2003).
38. Giles, R.H. et al. Interplay between VHL/HIF1α and Wnt/β-catenin pathways during colorectal tumorigenesis. Oncogene 25, 3065-3070 (2006).
39. Stella, M.C., Trusolino, L., Pennacchietti, S. & Comoglio, P.M. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol. Cell. Biol. 25, 3982-3996 (2005).
40. Potempa, S. & Ridley, A.J. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell 9, 2185-2200 (1998).
41. Ma, P.C. et al. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res. 65, 1479-1488 (2005).
42. Zhang, S.Z. et al. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol. Cancer Ther. 4, 1577-1584 (2005).
43. Bellusci, S. et al. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9, 1091-1099 (1994).
44. Rong, S., Segal, S., Anver, M., Resau, J.H. & Vande Woude, G.F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91, 4731-4735 (1994).
45. Wang, R., Ferrell, L.D., Faouzi, S., Maher, J.J. & Bishop, J.M. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell Biol. 153, 1023-1034 (2001).
46. Horiguchi, N. et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 21, 1791-1799 (2002).
47. Moshitch-Moshkovitz, S. et al. In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met. Neoplasia 8, 353-363 (2006).
48. Peruzzi, B. & Bottaro, D.P. Targeting the c-Met signaling pathway in cancer. Clin. Cancer Res. 12, 3657-3660 (2006).
49. Stein, U. et al. The metastasis-associated gene S100A4 is a novel target of β-catenin/T cell factor signaling in colon cancer. Gastroenterology 131, 1486-1500 (2006).
50. Workman, P. et al. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Cancer Metastasis Rev. 8, 82-88 (1989).